Amanote Research
Register
Sign In
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
Cells
doi 10.3390/cells8060547
Full Text
Open PDF
Abstract
Available in
full text
Date
June 6, 2019
Authors
Cinzia Antognelli
Sonia Moretti
Roberta Frosini
Efisio Puxeddu
Angelo Sidoni
Vincenzo N. Talesa
Publisher
MDPI AG
Related search
A New Aurora in Anaplastic Thyroid Cancer Therapy
International Journal of Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study
Oncology Letters
Cancer Research
Oncology
GBP-1 Acts as a Tumor Suppressor in Colorectal Cancer Cells
Carcinogenesis
Medicine
Cancer Research
Unusual Manifestation of Anaplastic Thyroid Cancer
Acta medica (Hradec Kralove)
Medicine
Treatment With Lenvatinib to Anaplastic Thyroid Cancer :
JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
Anaplastic Thyroid Cancer Evolved From Papillary Carcinoma
Archives of Otolaryngology–Head & Neck Surgery
Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer
Case Reports in Endocrinology
Endocrinology
Metabolism
Diabetes
miR-92b-3p Acts as a Tumor Suppressor by Targeting Gabra3 in Pancreatic Cancer
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
